Genmab A/S Stock

Genmab A/S Debt / Assets

The Debt-to-Assets Ratio of Genmab A/S (GMAB.CO) as of Aug 13, 2026 is 0.42. In the previous year, Debt-to-Assets Ratio was 0.02 — a change of 1,776.52% (higher).

Debt / Assets

0.42

YoY

1,776.52%

Last updated:

Debt-to-Assets Ratio of Genmab A/S is 2026 0.42 . Debt-to-Assets Ratio of Genmab A/S was 2025 0.02 . It decreases by 1,776.52% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Debt-to-Assets Ratio of Genmab A/S is 0.42 in 2026.

Debt-to-Assets Ratio of Genmab A/S changed from 0.02 to 0.42, representing a 1,776.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Genmab A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Leverage — Genmab A/S

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Genmab A/S